(Q37188487)

18 August 2017

1 reference

title

Prevention and treatment of acute GvHD. (English)

1 reference

18 August 2017

C Messina

1

1 reference

18 August 2017

M Faraci

2

1 reference

18 August 2017

V de Fazio

3

1 reference

18 August 2017

G Dini

4

1 reference

18 August 2017

M P Calò

5

1 reference

18 August 2017

E Calore

6

1 reference

18 August 2017

EBMT Paediatric Working Party

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Bone Marrow Transplantation

18 August 2017

published in

1 reference

18 August 2017

volume

41 Suppl 2

1 reference

18 August 2017

page(s)

S65-70

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2008.57

18 August 2017

exact match

0 references

cites work

Management of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Potential mechanisms of photopheresis in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Approaches to graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Assessing the potential role of photopheresis in hematopoietic stem cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Protective conditioning for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Pentostatin in steroid-refractory acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.57

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.57

1 reference

18 August 2017

1 reference